Background and basics 1: Robert Henderson, Richard Varcoe: The epidemiology and pathophysiology of coronary artery disease 2: Toby Rogers, Kenneth Kent, and Augusto D. Pichard: The history of interventional cardiology 3: Peter F. Ludman: Risk assessment and analysis of outcomes 4: David H. Roberts: Vascular access: femoral versus radial 5: Gurbir Bhatia, James Nolan: Radiation and percutaneous coronary intervention 6: Rod Stables: The 'golden rules' of percutaneous coronary intervention 7: Kevin O'Gallagher, Jonathan Byrne, and Philip MacCarthy: Routine management after percutaneous coronary intervention 8: Ayman Al-Saleh and Sanjit Jolly: Trial design and interpretation: statistics in PCI Percutaneous coronary intervention-related imaging 9: David Adlam, Annette Maznyczka, and Bernard Prendergast: Angiography: indications and limitations 10: Olivier Muller, Stephane Fournier, Bernard De Bruyne: Coronary physiology in clinical practice 11: Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald: The role of intravascular ultrasound in percutaneous coronary intervention 12: Ravinay Bhindi and Keith M. Channon: Optical Coherence Tomography in Percutaneous Coronary Intervention 13: A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman: Coronary computed tomography for the interventionalist 14: Theodoros D. Karamitsos and Stefan Neubauer: Cardiovascular magnetic resonance Percutaneous coronary intervention by clinical syndrome 15: Vasim Farooq and Patrick W. Serruys: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery 16: Bashir Alaour, Michael Mahmoudi and Nick Curzen: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome 17: Zulfiquar Adam and Mark A. de Belder: Primary percutaneous coronary intervention for ST elevation myocardial infarction 18: Divaka Perera and Natalia Briceno: Percutaneous coronary intervention in patients with impaired left ventricular function Percutaneous coronary intervention by lesion and patient subsets 19: Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefevre: Coronary bifurcation stenting: state of the art 20: Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet: Percutaneous coronary intervention for unprotected and protected left main stem disease 21: Colm G. Hanratty, James C. Spratt, Simon J. Walsh: Chronic total occlusions 22: George Kassimis and Adrian P. Banning: Revascularisation in patients with diabetes mellitus 23: Marko Noc and Peter Radsel: Out of Hospital Arrest: Role of PCI Adjunctive drug therapies in percutaneous coronary intervention 24: Vikram Khanna, Tony Gershlick and Nick Curzen: Current status of oralantiplatelet therapies 25: Tim Lockie: Current status of GP IIb/IIIa inhibitors 26: Stefanie Schupke, Steffen Massberg, and Adnan Kastrati: The role of bivalirudin in percutaneous coronary intervention 27: Simon J. Corbett and Nick Curzen: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents 28: Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies Complications of percutaneous coronary intervention 29: Peter A. McCullough: Contrast-induced acute kidney injury 30: Jaya Chandrasekhar, Adriano Caixeta, Philippe Genereux, George Dangas, and Roxana Mehran: In-stent restenosis in the drug-eluting stent era 31: Nikesh Malik, Amerjeet Banning, and Tony Gershlick: Stent thrombosis 32: Adam de Belder: Stent loss and retrieval 33: Mark Gunning and Chee Wah Khoo: Coronary artery perforation Special devices in percutaneous coronary intervention 34: Adam de Belder, Martyn Thomas, and Emanuele Barbato: Rotational atherectomy 35: Peter O'Kane and Simon Redwood: Laser 36: Giovanni Luigi De Maria and Adrian P. Banning: Saphenous Vein Graft PCI, Distal Protection and no-reflow 37: Adam J. Brown and Nick E. J. West: Bioresorbable Vascular Scaffolds 38: Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Imme: Access Sites and the TAVI Procedure 39: Mohamed Abdel-Wahab and John Jose: Selection of TAVI Prostheses 40: Muhammed Zeeshan Khawaja and Simon Redwood: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat 41: Michael Bellamy and Christopher Baker: Transcatheter Mitral Valve Repair 42: Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat: Transcatheter Mitral Valve Replacement Other Non-coronary percutaneous interventions 43: Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith: Percutaneous device closure of atrial septal defect and patent foramen ovale 44: Alec Vahanian, Dominique Himbert, Eric Brochet, Gregory Ducrocq, and Bernard Iung: Mitral balloon valvuloplasty 45: Charles Knight, Saidi Mohiddin, and Constantinos O'Mahony: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy 46: Iqbal Malik and Mohamed Hamady: Carotid artery stenting 47: Tim Betts: Left Atrial Appendage Occlusion The Future 48: Kenneth Chan, Manish Saxena, and Melvin D. Lobo: Novel Therapies for Hypertension 49: Giora Weisz: Robotic PCI 50: Fizzah Choudry and Anthony Mathur: Stem Cell Therapy and Delivery